Skip to main content
OpenTrials

Clinical trial condition

Metastatic Colorectal Cancer

Explore clinical trials studying Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

386 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer trial results

Completed

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

NCT00819780

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +18 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Huntsville, Alabama, United States
  • Research Site Berkeley, California, United States
  • Research Site Beverly Hills, California, United States
View all 95 locations
View Trial Details
Completed

A Screening Study Targeting Tumor-specific Antigens

NCT05158621

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Miami Cancer Institute Miami, Florida, United States
  • Advanced Research Tamarac, Florida, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • The Christ Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01001377

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +15 more
Locations
  • Research Site Stockton, California, United States
  • Research Site Boynton Beach, Florida, United States
  • Research Site Wichita, Kansas, United States
  • Research Site Temple, Texas, United States
View all 152 locations
View Trial Details

Related conditions